Sentences with phrase «animal health businesses in»

In our research - driven Animal Health business, Boehringer Ingelheim continually invests more than 11 % of net sales of the Animal Health business in R&D.

Not exact matches

Growth in the animal health business (+13 %) was another key catalyst, helping to offset continued generic erosion in the ZETIA / VYTORIN franchise -LRB--18 %).

Under now - retired CEO John Lechleiter, Lilly continued to build up its animal health business, buying Boehringer Ingelheim's pet vaccines last fall in an $ 885 million deal.

During the quarter, Lilly's animal health revenues fell 9 % year - over-year to $ 706.2 million, which the company blamed on irregular wholesale buying patterns in companion animal health and an overall drop in demand on the food - animal side of the business.

And Pfizer made a noteworthy transaction in February of 2013, when it spun off its animal health business into a new company, Zoetis (ZTS).

In a demonstration of the continued strength of a healthcare team hired in 2010, Jefferies was a joint bookrunner in the largest healthcare IPO of 2013, raising $ 2.6 billion for Zoetis — Pfizer's animal health business spin - off — on January 3In a demonstration of the continued strength of a healthcare team hired in 2010, Jefferies was a joint bookrunner in the largest healthcare IPO of 2013, raising $ 2.6 billion for Zoetis — Pfizer's animal health business spin - off — on January 3in 2010, Jefferies was a joint bookrunner in the largest healthcare IPO of 2013, raising $ 2.6 billion for Zoetis — Pfizer's animal health business spin - off — on January 3in the largest healthcare IPO of 2013, raising $ 2.6 billion for Zoetis — Pfizer's animal health business spin - off — on January 31.

Tags: Animal Emergency Center, Tulsa, Veterinary Posted in Business Closeups, Pet Health, TulsaPetsOnline No Comments»

Pet Business: In the past, Bayer Animal Health's products were only available through a veterinarian.

Pfizer Animal Health, one of six business units of Pfizer Inc (NYSE: PFE), is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $ 300 million annAnimal Health, one of six business units of Pfizer Inc (NYSE: PFE), is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $ 300 million annanimal prescription medicines and vaccines, investing an estimated $ 300 million annually.

Certificate programs are unique to the University of Florida (UF), and Maddie's ® Professional Certificate in Shelter Medicine is one of five certificates offered at UF, joining other intensive programs in Food Animal Medicine, Aquatic Animal Health, Veterinary Business Management, and the One Health initiative.

Pfizer Animal Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Animal Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Health, a business unit of Pfizer Inc, is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic animal health vaccines, medicines, diagnostic products and genetic health vaccines, medicines, diagnostic products and genetic tests.

LifeLearn's ECOsystem is a comprehensive suite of custom digital solutions designed to help veterinary teams and animal health companies in the areas of education, communication, and ultimately, optimization of their business.

Cunningham's appointment is the latest in a series of significant developments within the Bimeda North America business, and follows on from strategic acquisitions last year within the equine animal health sector.

It's what option allows the animal health business to realize its full potential, so as successful as we've been, what option allows the animal health business to achieve its full potential in the marketplace?

Henry Schein Animal Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United States, and the U.S animal health business of Henry Schein, Inc. (NASDAQ: Animal Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United States, and the U.S animal health business of Henry Schein, Inc. (NASDAQ: Health, based in Dublin, Ohio, is the leading companion animal health distribution company in the United States, and the U.S animal health business of Henry Schein, Inc. (NASDAQ: animal health distribution company in the United States, and the U.S animal health business of Henry Schein, Inc. (NASDAQ: health distribution company in the United States, and the U.S animal health business of Henry Schein, Inc. (NASDAQ: animal health business of Henry Schein, Inc. (NASDAQ: health business of Henry Schein, Inc. (NASDAQ: HSIC).

Ever since Pfizer Inc. hired J.P. Morgan in July to evaluate strategic options for its animal health business, the unit has faced increased scrutiny and speculation.

About Pfizer Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Health Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Animal Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Health, a business unit of Pfizer Inc., is a world leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic animal health vaccines, medicines, diagnostic products and genetic health vaccines, medicines, diagnostic products and genetic tests.

However, many business owners are accommodating of those with mental health needs, and are willing to let emotional support animals in; others businesses are unaware of this law, and will let an emotional support animal in regardless.

If these operations are even regulated, which many are not, APHIS or a state agency or law enforcement typically turn a blind eye, dithering over their authority to shut them down, pretending these are somehow legitimate «businesses» that should be supported, ignoring that these sleazy operators make their money from animal cruelty and leave communities with unwanted dogs in their shelters, environmental and health hazards from improperly disposed of carcasses and waste, infestation, and wastewater and other sewage problems.

Pfizer Animal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $ 300 million annAnimal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal prescription medicines and vaccines, investing an estimated $ 300 million annanimal prescription medicines and vaccines, investing an estimated $ 300 million annually.

About Zoetis Zoetis, a business unit of Zoetis Inc., is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways.

About Pfizer Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Animal Health Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Health Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic Health, a business unit of Pfizer Inc., is a global leader in the discovery, development and manufacture of innovative animal health vaccines, medicines, diagnostic products and genetic animal health vaccines, medicines, diagnostic products and genetic health vaccines, medicines, diagnostic products and genetic tests.

«We are pleased to partner with Zoetis, the leader in animal health, to bring our company's flagship business solution to more veterinary practices and help them effectively address their financial challenges,» said Fee Technology founder Dan Zalta.

We are pleased to now lead the profession in support of this very important initiative to take the fear out of visiting the veterinarian, at a time when solutions are needed to reverse the decline in veterinary visits,» said Dr. Karen Padgett, Chief Operating Officer, Ceva Animal Health Companion Animal Business Unit.

We expect the launch of Feliway MultiCat pheromone to extend our market leadership in this area,» said Dr. Karen Padgett, Chief Operating Officer, Ceva Animal Health Companion Animal Business Unit.

Michael O'Bryan is the Executive Vice President of Business Operations for the Virbac Corporation, a leading companion animal health company with products in the pharmaceutical, dermatological and oral hygiene markets for pets based in Fort Worth, Texas.Prior to joining Virbac, O'Bryan managed the marketing and sales departments at Purina.

Topics: Rabbit and rodent dentistry; Exotic animal surgery; Infectious diseases; Herd health; Rescue and rehab; Reptile medicine and surgery; Business of exotic animal practice; Legal issues in the veterinary profession

As Chairman, Schwichtenberg presides over all meetings of the Board of Directors, the governing body of APPA.She also serves in a leadership advisory role guiding APPA's industry - wide activities.Schwichtenberg previously served as Vice Chairman of the Board for APPA.Schwichtenberg is the President and Chief Executive Officer of the Central Garden & Pet strategic business unit Central Life Sciences.Specializing in the development, manufacturing and marketing of category - leading product brands such as Farnam, Zodiac, Bio Spot, Horse Health Products, Adams, PreStrike and Platform Feeds, Central Life Sciences focuses on improving the quality of life for companion animals.Prior to Central Life Sciences, Schwichtenberg was Vice President and general manager of the Consumer Animal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health proHealth Products, Adams, PreStrike and Platform Feeds, Central Life Sciences focuses on improving the quality of life for companion animals.Prior to Central Life Sciences, Schwichtenberg was Vice President and general manager of the Consumer Animal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health proAnimal Health Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health proHealth Division of Sandoz, Inc. (now Novartis, Inc.), a worldwide leader in human pharmaceuticals and animal health proanimal health prohealth products.

The changes, while difficult, are aligned with Elanco's objectives to maintain a competitive advantage in the continually changing animal health business.

«Fran is recognized in the health care industry for being both a visionary leader and a strategic entrepreneur, with a track record for bringing out the best in people to drive growth and business excellence,» said Lonnie Shoff, Chief Executive Officer, Global Animal Health and Strategic Partnership health care industry for being both a visionary leader and a strategic entrepreneur, with a track record for bringing out the best in people to drive growth and business excellence,» said Lonnie Shoff, Chief Executive Officer, Global Animal Health and Strategic Partnership Health and Strategic Partnership Group.

Such risks and uncertainties include, among other things, the possibility that the initial public offering will not be consummated within the anticipated time period or at all, including as the result of regulatory, market or other factors; risks relating to Pfizer Animal Health as a standalone business as the result of the variables and uncertainties inherent in business, financial and operating performance, including, among other things, competitive developments and general economic, political, business, industry, regulatory and market conditions; and the potential for disruption to Pfizer's Animal Health business as the result of the initial public offering.

In his new position, Dirksmeier leads the largest portion of Henry Schein's global animal health business.

Henry Schein Animal Health in North America accounts for nearly half of Henry Schein, Inc.'s global animal health business, which had sales of approximately $ 2.9 billion inAnimal Health in North America accounts for nearly half of Henry Schein, Inc.'s global animal health business, which had sales of approximately $ 2.9 billion inHealth in North America accounts for nearly half of Henry Schein, Inc.'s global animal health business, which had sales of approximately $ 2.9 billion inanimal health business, which had sales of approximately $ 2.9 billion inhealth business, which had sales of approximately $ 2.9 billion in 2014.

With more than 9,000 employees, the business markets its products in more than 120 countries with operations in developed and emerging markets and provides comprehensive animal health solutions to veterinarians and the livestock farmers and companion animal owners they support.

Preparations Underway to File Potential Initial Public Offering of Minority Ownership Stake in Animal Health Business Standalone Company to Be Called ZoetisTM

This release contains forward - looking information that involves substantial risks and uncertainties about the intention to file a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of a minority ownership stake in Pfizer's Animal Health business, including the anticipated timing of such a transaction and the potential benefits to Pfizer.

Addition of King Pharmaceuticals» Alpharma business broadens Pfizer Animal Health's best - in - class portfolio

NEW YORK, N.Y., JUNE 7 - Pfizer Inc. (NYSE: PFE) today announced the next steps in the strategic alternatives review process for the company's Animal Health business.

Selected companies present their vision and business plan to venture capital funds, investment firms and animal health companies in August.

«Henry Schein's companion animal health distribution business is the largest in North America and our customers consistently rely on us for a comprehensive line of products and services, including a full range of veterinary diagnostics products such as instruments, consumables and rapid assays,» said Lonnie Shoff, the Chief Executive Officer of Henry Schein's Global Animal Health and Strategic Partnership animal health distribution business is the largest in North America and our customers consistently rely on us for a comprehensive line of products and services, including a full range of veterinary diagnostics products such as instruments, consumables and rapid assays,» said Lonnie Shoff, the Chief Executive Officer of Henry Schein's Global Animal Health and Strategic Partnership health distribution business is the largest in North America and our customers consistently rely on us for a comprehensive line of products and services, including a full range of veterinary diagnostics products such as instruments, consumables and rapid assays,» said Lonnie Shoff, the Chief Executive Officer of Henry Schein's Global Animal Health and Strategic Partnership Animal Health and Strategic Partnership Health and Strategic Partnership Group.

The acquisition was completed in December 2010 and the integration of the business was announced to Pfizer Animal Health customers on July 5, 2011, when Pfizer Animal Health formally assumed the customer service and shipping of all Synbiotics products.

McNeil's appointment is the latest in a series of significant developments within the Bimeda North America business, and follows on from strategic acquisitions last year within the equine animal health sector.

Four companies headquartered in the KC Animal Health Corridor are among 18 young businesses that will present their innovative ideas and growth plans to hundreds of potential investors and partners during the annual Investment Forum.

WHAT?!?! People can use Public Health degrees in the animal welfare business?

The third - annual Henry Schein Cares Medal will be presented next year to three finalists in the animal health category and in two other business sectors: oral health and human medicine.

What the Hillsborough Animal Health Foundation is most interested in protecting, it seems, is the business interests of its members.

A co-founder of Banfield Pet Hospital and an aviation business owner have joined the 16 - member board of trustees at Morris Animal Foundation, a longtime leader in the funding of animal health stAnimal Foundation, a longtime leader in the funding of animal health stanimal health studies.

Part of this time he was based in Europe, working on the global companion animal health business with focus on integrating a previous acquisition.

«In 2017, Zoetis became the first animal health company to deliver more than $ 5 billion in revenue as we continued to demonstrate the strength of our business model and the growth opportunities that are uniquely available in animal health,» CEO Juan Ramón Alaix saiIn 2017, Zoetis became the first animal health company to deliver more than $ 5 billion in revenue as we continued to demonstrate the strength of our business model and the growth opportunities that are uniquely available in animal health,» CEO Juan Ramón Alaix saiin revenue as we continued to demonstrate the strength of our business model and the growth opportunities that are uniquely available in animal health,» CEO Juan Ramón Alaix saiin animal health,» CEO Juan Ramón Alaix said.